Black-White Cancer Mortality Gap Decreasing in Some Age Groups
WEDNESDAY, Feb. 20, 2019 -- Cancer death rates are decreasing faster in blacks than whites in the United States, according to a report published online Feb. 14 in CA: A Cancer Journal for Clinicians. Noting that African-American/black individuals... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 20, 2019 Category: Pharmaceuticals Source Type: news

Glottic Carcinoma Can Be HPV-Related Disease in Young Adults
WEDNESDAY, Feb. 20, 2019 -- An increased incidence of glottic carcinoma related to human papillomavirus (HPV) has been documented in recent years among young patients, according to a study published online Jan. 27 in the Annals of Otology, Rhinology... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 20, 2019 Category: Pharmaceuticals Source Type: news

Cervical cancer will be 'ELIMINATED by 2100' thanks to life-saving HPV vaccine and improved testing
Researchers from the Cancer Council New South Wales in Sydney, Australia, made the prediction - which could see 1,000 British women saved from the disease annually. (Source: the Mail online | Health)
Source: the Mail online | Health - February 20, 2019 Category: Consumer Health News Source Type: news

Lawyer whose cough was dismissed as 'bad flu' for TWO YEARS has blood cancer
Karla Lora-Cabán, 24, of Santo Domingo, Dominican Republic, was just 16 when she lost one-and-a-half stone (21lbs) and developed asthma. Doctors prescribed syrups and iron tablets. (Source: the Mail online | Health)
Source: the Mail online | Health - February 20, 2019 Category: Consumer Health News Source Type: news

Medical News Today: Aggressive brain cancer: Why does immunotherapy fail?
New research helps explain why some glioblastoma tumors respond to immunotherapy whereas the majority of these aggressive cancers do not. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 20, 2019 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Cancer warning - have you got smelly poo? This is when you should see a doctor
CANCER symptoms vary depending on which part of the body is affected by a tumour. You could be at risk of deadly tumour signs if you notice this smell after doing a poo. It could be a warning symptom of pancreatic cancer. Should you see a doctor? (Source: Daily Express - Health)
Source: Daily Express - Health - February 20, 2019 Category: Consumer Health News Source Type: news

Uganda: Mulago, Cancer Institute Fight Over Patients Hostel
[Monitor] Kamapala -The managers of Mulago National Referral Hospital and Uganda Cancer Institute (UCI) are locked in a dispute over the use of a house that Uganda Women's Health Initiative built as hostel for female cancer patients. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 20, 2019 Category: African Health Source Type: news

Should You Get Tested for the 'Breast Cancer Genes'?
Title: Should You Get Tested for the 'Breast Cancer Genes'?Category: Health NewsCreated: 2/19/2019 12:00:00 AMLast Editorial Review: 2/20/2019 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 20, 2019 Category: Cancer & Oncology Source Type: news

Lower recall rate makes DBT better for breast screening
Digital breast tomosynthesis (DBT) has a lower recall rate compared with full-field...Read more on AuntMinnie.comRelated Reading: More states seek to expand mammography, DBT coverage DBT is comparable to FFDM for detecting benign lesions DBT finds more invasive, early-stage cancers Are better clinical results from DBT worth the cost? DBT betters mammo performance in screening, diagnosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 20, 2019 Category: Radiology Source Type: news

Cervical cancer could be eliminated in most countries by 2100 – research
Millions of cases could be prevented with high HPV vaccine and screening coverageCervical cancer could be effectively eliminated in most countries around the world by the end of the 21st century, according to research.The HPV (human papilloma virus) vaccine, which protects against the virus that causes most cases, has dramatically reduced incidences of cervical cancer wherever uptake has been high. There are hopes that the jab given to young girls, together with occasional HPV screening, could end the scourge of a disease that kills more than 300,000 women globally every year.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - February 20, 2019 Category: Science Authors: Sarah Boseley Health editor Tags: Cervical cancer HPV vaccine Health Society Vaccines and immunisation Biology Science World news World Health Organization Australia news Europe Japan Asia Pacific Source Type: news

New 'smart drug' shows promise for metastatic triple-negative breast cancer
(Columbia University Irving Medical Center) A clinical trial at NewYork-Presbyterian/Columbia and other centers found that patients responded to a new 'smart drug' for women with an aggressive form of breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 20, 2019 Category: Cancer & Oncology Source Type: news

Antibody-drug conjugate shows promise against metastatic triple-negative breast cancer
(Massachusetts General Hospital) Treatment with the experimental drug sazituzumab govitecan produced a significant treatment response in patients with difficult-to-treat metastatic triple-negative breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 20, 2019 Category: Cancer & Oncology Source Type: news

CASSINI Trial publishes data on preventing blood clots in cancer patients
(Fred Hutchinson Cancer Research Center) The first clinical study investigating the use of the direct oral anticoagulant, rivaroxaban, to prevent blood clots in patients with cancer at high-risk published today in the New England Journal of Medicine. The study found no significant reduction in venous thromboembolism or death in the overall 180-day trial period; however, the researchers did observe a lower incidence of these events while patients were actively on the study drug, or during the on-treatment period. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 20, 2019 Category: Cancer & Oncology Source Type: news

Ofatumumab Shows Limited Activity in Previously Untreated Follicular Lymphoma
In this study, single-agent ofatumumab did not show superiority to rituximab or obinutuzumab, raising the question of whether ofatumumab should have a role in the treatment of follicular lymphoma. (Source: CancerNetwork)
Source: CancerNetwork - February 20, 2019 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news

Is NIFTP Truly a Non –Thyroid Cancer Diagnosis?
According to the American Thyroid Association guidelines, noninvasive follicular thyroid neoplasm with papillary-like features is benign. (Source: CancerNetwork)
Source: CancerNetwork - February 20, 2019 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

Assessing Quality of Life After Thyroidectomy
Researchers evaluated the incidence of physical, psychological, and lifestyle effects among patients with  differentiated thyroid cancer. (Source: CancerNetwork)
Source: CancerNetwork - February 20, 2019 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

Could Conservative Management of Adnexal Masses Lead to Ovarian Cancer?
Researchers tested whether conservative management of adnexal masses classified as benign could lead to subsequent malignant ovarian cancer. (Source: CancerNetwork)
Source: CancerNetwork - February 20, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Decreasing Clinical Trial Participation Barriers
Cancer Network speaks with Joseph Unger, PhD, about ways to decrease the barriers for cancer patients to enroll in clinical trials. (Source: CancerNetwork)
Source: CancerNetwork - February 20, 2019 Category: Cancer & Oncology Authors: Joseph Unger, PhD, MS Source Type: news

Study finds way to potentially improve immunotherapy for cancer
(Cedars-Sinai Medical Center) A new study has identified a drug that potentially could make a common type of immunotherapy for cancer even more effective. The study in laboratory mice found that the drug dasatinib, which is FDA-approved to treat certain types of leukemia, greatly enhances responses to a form of immunotherapy that is used against a wide range of other cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 20, 2019 Category: Cancer & Oncology Source Type: news

Press registration now open for Nutrition 2019
(American Society for Nutrition) Reporters and bloggers are invited to attend Nutrition 2019, the flagship meeting of the American Society for Nutrition. The meeting will be held June 8-11, 2019 at the Baltimore Convention Center. #Nutrition2019 is your source for high-quality nutrition research and news. Register for a complimentary press pass or follow along virtually to get the latest scientific findings and explore their implications for practice, policy and industry. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 20, 2019 Category: Cancer & Oncology Source Type: news

Report says health systems are key to improving cancer outcomes in the United States
(American Cancer Society) A new report says without a national investment and commitment to transforming health care delivery in the United States, many people will not benefit from the substantial progress made against cancer. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - February 20, 2019 Category: International Medicine & Public Health Source Type: news

New AI able to identify and predict the development of cancer symptom clusters
(University of Surrey) Cancer patients who undergo chemotherapy could soon benefit from a new AI that is able to identify and predict the development of different combinations of symptoms -- helping to alleviate much of the distress caused by their occurrence and severity. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 20, 2019 Category: International Medicine & Public Health Source Type: news

Antibody therapy training phagocytes to destroy tumors now tested on patients
(University of Turku) Developed by researchers at the University of Turku in Finland, an immunotherapeutic antibody therapy re-educates macrophages to activate passivated cytotoxic T cells to kill cancer. The antibody therapy prevented the growth of tumours in several mouse models. The development of the therapy has now progressed to patient testing in a phase I/II clinical trial. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 20, 2019 Category: International Medicine & Public Health Source Type: news

Study finds melanoma brain metastases are immunosuppressive with treatment-resistant metabolism
(University of Texas M. D. Anderson Cancer Center) Melanoma tumors that have spread to the brain are equipped to thwart immunotherapies and targeted therapies that succeed against tumors growing in other sites. Researchers at the University of Texas MD Anderson Cancer Center report in Cancer Discovery that the heavy reliance of these tumors on a specific metabolic pathway presents a potentially new therapeutic against these lethal tumors. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 20, 2019 Category: International Medicine & Public Health Source Type: news

New method to detect cancer cells faster, potentially improving outcomes
(Purdue University) A new Purdue University technique to analyze proteins expressed on cancer cells shows promise in more rapidly detecting these cell types in patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 20, 2019 Category: International Medicine & Public Health Source Type: news

New compound could help treat ovarian cancer
(University of Sheffield) Scientists from the University of Sheffield have discovered a compound that could be more effective in treating certain cancers than standard chemotherapy. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 20, 2019 Category: Biology Source Type: news

The Mark Foundation funds 14 new cancer innovation projects
(The Mark Foundation for Cancer Research) The Mark Foundation for Cancer Research has selected 14 outstanding scientific research projects for ASPIRE Awards. Designed to answer key proof-of-concept questions in a short timeframe, the ASPIRE (Accelerating Scientific Platforms and Innovative Research) program funds high risk, high reward approaches to solving complex problems in cancer research that tend to fall outside the scope of other funding opportunities. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 20, 2019 Category: International Medicine & Public Health Source Type: news

Natural compound from the Pacific yew tree may be the next big thing in cancer treatments
(Natural News) Some people only believe in the pills their doctors give them. If you mention an herbal remedy, they’ll laugh it off and say they’ll stick to their prescriptions. That’s their right, of course, but it’s also a rather curious attitude to have when you consider the fact that many popular drugs were actually developed... (Source: NaturalNews.com)
Source: NaturalNews.com - February 20, 2019 Category: Consumer Health News Source Type: news

Screen for Colon Cancer at 45?
(MedPage Today) -- Peter Ubel, MD, explains why this might not be advantageous (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - February 20, 2019 Category: Gastroenterology Source Type: news

Patient experience winner: Joseph Flynn | Norton Medical Group
Beyond his administrative duties, Flynn coordinates Cancer Beats, a community program that connects patients with music therapists. Flynn has even volunteered his time to play guitar with patients and perform a concert with them at a cancer fundraiser. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 20, 2019 Category: Biotechnology Source Type: news

Patient experience winner: Joseph Flynn | Norton Medical Group
Beyond his administrative duties, Flynn coordinates Cancer Beats, a community program that connects patients with music therapists. Flynn has even volunteered his time to play guitar with patients and perform a concert with them at a cancer fundraiser. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - February 20, 2019 Category: American Health Source Type: news

USPSTF Says Screen Women With Higher Risk for BRCA Mutations
Those with positive results should be provided with genetic counseling, testing if indicated (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 20, 2019 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Internal Medicine, Oncology, Pathology, Institutional, Source Type: news

Inappropriate Use of Fentanyl Preps Seen Despite Awareness
Claims data show many prescribed transmucosal immediate - release fentanyl were opioid - nontolerant (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 20, 2019 Category: Cancer & Oncology Tags: Family Medicine, Internal Medicine, Neurology, Oncology, Pharmacy, Anesthesiology & amp; Pain, Journal, Source Type: news

Are Primary Care Doctors Prepared to Discuss Cancer Treatment?
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - February 20, 2019 Category: Cancer & Oncology Source Type: news

Acupuncture may help ease troublesome menopausal symptoms
Linked to reductions in hot flushes, sweating, mood swings, sleep disturbance, skin and hair problems, although placebo effect can ’t be ruled out Related items fromOnMedica Antibiotic scrip rates lower in CAM-trained practices Vaginal oestradiol tablet no better than placebo Is crowdfunding for cancer patients paying for ‘quackery’? Cancer patients using complementary meds die sooner Don ’t deny menopausal women HRT and explain pros and cons, doctors told (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 20, 2019 Category: UK Health Source Type: news

Merck's Keytruda fails late-stage study in liver cancer patients
Merck& Co Inc said on Tuesday its cancer drug Keytruda failed the main goals of a late-stage trial and did not extend life of patients with a type of liver cancer. (Source: Reuters: Health)
Source: Reuters: Health - February 19, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Vitamin D can increase your cancer survival rate by 52%, research concludes
(Natural News) Everyone is looking for ways to prevent cancer, making little changes here and there according to what the latest studies say. Simple acts like cutting out processed meat, getting more exercise, and switching to organic could well add up to provide significant protection over time, but what if you already have cancer and... (Source: NaturalNews.com)
Source: NaturalNews.com - February 19, 2019 Category: Consumer Health News Source Type: news

SBRT Nearly Doubles Survival for Early, Inoperable Lung Cancer
(MedPage Today) -- Establishes evidence for peripherally located stage I NSCLC (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 19, 2019 Category: Hematology Source Type: news

Study: Glyphosate-Based Herbicide Exposure Increases Cancer Risk By 41 Percent
BERKELEY, Calif. - A team of researchers led by a scientist at the University of California Berkeley released a study on Feb. 5 that concludes that "the overall meta-relative risk" of non-Hodgkin lymphoma (NHL) in a person exposed to glyphosate-based herbicides (GBHs) is 41 percent higher than in those who are not exposed to the chemical. (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - February 19, 2019 Category: Medical Law Source Type: news

Plaintiffs: Monsanto's 'Fraud' About Glyphosate Liable for Causing Their Cancers
ST. LOUIS - A Colorado cancer victim on Feb. 11 sued Monsanto Co. in Missouri federal court, alleging that it committed "scientific fraud" and "colluded" with the Environmental Protection Agency in promoting as safe the herbicide Roundup, which contains that active ingredient glyphosate. The attorneys representing the man have filed identical complaints on behalf of multiple plaintiffs (Steven Burchfield v. Monsanto Co., No. 19-205, E.D. Mo.). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - February 19, 2019 Category: Medical Law Source Type: news

Intuitive Surgical wins FDA clearance for robotic-assisted lung biopsy system
Intuitive Surgical’s Ion system includes an articulating robotic catheter able to navigate through small and tortuous airways during lung biopsy procedures. [Image courtesy of Intuitive Surgical]Intuitive Surgical (NSDQ:ISRG) said today that FDA has cleared its Ion system — a robotic-assisted, catheter-based platform meant to enable minimally invasive biopsy deep within the lung. Sunnyvale, Calif.–based Intuitive plans to start selling the Ion system in the U.S. in a measured fashion; it’ll start shipping to customers in coming months. The Ion system includes an articulating robotic cathet...
Source: Mass Device - February 19, 2019 Category: Medical Devices Authors: Chris Newmarker Tags: 510(k) Business/Financial News Featured Food & Drug Administration (FDA) News Well Robotics Surgical Intuitive Surgical surgical robotics Source Type: news

At the Forefront of ADC Manufacturing
ADC BIO ’s innovative technology is helping to usher in oncology’s new age of therapeutic agents (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - February 19, 2019 Category: Pharmaceuticals Source Type: news

Women want screening mammography results quickly
Women want to receive results from their screening mammograms quickly, according...Read more on AuntMinnie.comRelated Reading: Women unaware of importance of baseline mammography Mammo recalls don't keep women from other tests Women want to know their breast cancer risk (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 19, 2019 Category: Radiology Source Type: news

Don't Screen Asymptomatic Adults for Pancreatic Cancer
Based on current evidence, the U.S. Preventive Services Task Force recently recommended against screening asymptomatic adults for pancreatic cancer -- a " D " recommendation. (Source: AAFP News)
Source: AAFP News - February 19, 2019 Category: Primary Care Source Type: news

Should You Get Tested for the ‘ Breast Cancer Genes ’ ?
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 19, 2019 Category: Cancer & Oncology Tags: Gynecology, Oncology, Research, Preventive Medicine, News, Source Type: news

Oncotype DX Not Cost - Effective for Low - Risk Breast Cancer
Incremental cost - effectiveness ratio varies across clinical risk groups, sensitive to patient age (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 19, 2019 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pathology, Journal, Source Type: news

Joining a clinical trial is too hard for many cancer patients
(Reuters Health) - Only a small fraction of cancer patients volunteer for clinical trials. The reason, a new study suggests, is not that they don't want to, but that the system makes it too hard. (Source: Reuters: Health)
Source: Reuters: Health - February 19, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

' Exciting Times' With Immunotherapy for Kidney Cancer'Exciting Times' With Immunotherapy for Kidney Cancer
New combinations with immunotherapy are going to change the standard of care in metastatic renal cell carcinoma, but questions remain, and there are technicalities to consider, according to some experts.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 19, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Umbilical Cord Blood Expanded Ex Vivo Shortens Neutrophil Recovery Time (CME/CE)
(MedPage Today) -- NiCord grafts allowed transplantation without co-infusion of second, unmanipulated umbilical cord blood unit (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 19, 2019 Category: Hematology Source Type: news

Doctors' Kids Hear the Darnedest Things Doctors' Kids Hear the Darnedest Things
Reader reactions to the experience of one physician whose cancer diagnosis led to a startling, and disconcerting, education in just how much her children had learned about medicine through her.Medscape Family Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 19, 2019 Category: Consumer Health News Tags: Family Medicine/Primary Care Article Source Type: news